Adrian Jubb

Adrian Jubb, MD PhD, is an accomplished leader in oncology and neurology clinical development, currently serving as the Head of Oncology and Neurology Clinical Development at Corcept Therapeutics since June 2024, and as an Advisor at Kanvas Biosciences. Previously, Adrian held prominent roles including Executive Vice President and Head of Clinical Development at Zentalis Pharmaceuticals, Chief Medical Officer at Flare Therapeutics, and Head of Clinical Oncology and Neurology at 23andMe. With a strong background in clinical trials and drug development, Adrian has been instrumental in leading successful IND-enabling studies and clinical programs for various innovative therapies in areas such as solid tumors and advanced urothelial carcinoma. Adrian's educational credentials include a PhD in Medicine and an MBChB (Hons) from the University of Leeds, as well as FRCPath from the Royal College of Pathologists.